Microcurrent for Healing Autogenous Skin Donor Sites
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A decrease in donor site wound healing time (as assessed by the research team) of 2 days will be observed with the addition of active microcurrent to silver- coated nylon dressing.
| Condition | Intervention |
|---|---|
|
Burns |
Device: Microcurrent with Silver Coated Dressing Device: Silver coated dressing without active microcurrent |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Prospective, Randomized, Controlled Study of the Efficacy of a Silver-coated Nylon Dressing Plus Active or Sham Microcurrent for Healing Autogenous Skin Donor Sites |
- Decrease in donor site wound healing time of 2 days [ Time Frame: 12 days ] [ Designated as safety issue: No ]
- Reduce pain and infection [ Time Frame: 12 days ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 30 |
| Study Start Date: | December 2007 |
| Estimated Study Completion Date: | December 2013 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Group 1
Use of the active microcurrent with the silver-coated dressing
|
Device: Microcurrent with Silver Coated Dressing
Microcurrent stimulation from 15-50 microamps
Other Name: Silver Nylon dressing
|
|
Sham Comparator: Group 2
Use a sham microcurrent with the silver coated dressing
|
Device: Silver coated dressing without active microcurrent
Silver coated dressing only
Other Name: Silver nylon dressing without microcurrent
|
Detailed Description:
The specific aims of the study are to evaluate the impact of active versus sham direct microcurrent application to silver nylon dressings in the treatment of donor sites for partial thickness thermal injuries. The primary endpoint is wound-closure time (re-epithelialization of 90% or more of wound surface). Secondary endpoints include pain and infection. Exploratory assessments of clinical outcomes, including inflammation, and pain medication (type, dosage, route, timing) will also be conducted.
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- between 18-65 years of age
- burn less than 30% total body surface area
- burns not involving donor site area
- you need skin grafting to cover burns
- agree not to use other electronic devices that generate current during your study participation
- agree to come back for follow up visits at least every other day after discharge from hospital until donor site is healed
Exclusion Criteria:
- you have an illness that may affect how your wound heals such as diabetes, blood clotting disorder, cirrhosis, liver failure, peripheral vascular disease
- you are taking medications that could affect how your wound heals such as steroids, Plavix, Coumadin
- you have an infection of the skin or your bloodstream
- you are pregnant or nursing
- you are sensitive or allergic to silver or nylon
- your burn wounds are more than 30% of your total body surface area
- your site was previously harvested for grafting
- you have an implantable pacemaker device
Contacts and Locations| United States, Texas | |
| USAISR | |
| Fort Sam Houston, Texas, United States, 78234 | |
| Principal Investigator: | Leopoldo C Cancio, MD | United States Army Institute of Surgical Research |
More Information
Publications:
| Responsible Party: | United States Army Institute of Surgical Research |
| ClinicalTrials.gov Identifier: | NCT00558701 History of Changes |
| Other Study ID Numbers: | H-07-003, I.2007.128 |
| Study First Received: | November 13, 2007 |
| Last Updated: | February 25, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by United States Army Institute of Surgical Research:
|
burns donor site healing microcurrent |
ClinicalTrials.gov processed this record on May 23, 2013